Skip to main content
Toggle navigation
Search
Home
Back
Like
Facebook
Tweet
Print
Session 13: Debate: Should We Quantify HER-2 Expression for Use of TDXd and Other ADCs?
Session 13: Debate: Should We Quantify HER-2 Expression for Use of TDXd and Other ADCs? - NO
Thursday, November 2, 2023
3:45 PM – 4:00 PM
ET
Presenter(s)
Paolo Tarantino, MD
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts